ADAM15 correlates with prognosis, immune infiltration and apoptosis in hepatocellular carcinoma. 2021

Jun Hui Xu, and Yong Jun Guan, and Yi Chao Zhang, and Zhen Dong Qiu, and Yu Zhou, and Chen Chen, and Jia Yu, and Wei Xing Wang
Department of Hepatobiliary Surgery, Renmin Hospital of Wuhan University, Wuhan, China.

ADAM15 is highly expressed in malignant tumors and is correlated with tumor progression. However, the role of ADAM15 in hepatocellular carcinoma (HCC) remains unclear. In the study, our results indicated that ADAM15 was highly expressed in HCC tissues and cells compared with corresponding tissues and liver cells. Overexpression of ADAM15 was linked to poor prognosis, and was an independent risk factor for HCC prognosis. Besides, analysis of immune infiltration indicated that ADAM15 expression was related to tumor infiltrating lymphocytes based on the TIMER, TISIDB and GEPIA databases. Many immune checkpoint gene expression was associated with ADAM15 expression. Functional enrichment analyses indicated that apoptosis, cell adhesion was enriched. ADAM15 knockdown promoted apoptosis and suppressed proliferation, migration and invasion of liver cancer cells. The findings of western blot showed that ADAM15 knockdown reduced the expression of Bcl-2, Vimentin, N-Cadherin and Snail, and elevated the expression of Bax, E-cadherin and ZO-1. However, overexpression of ADAM15 had the opposite results. Collectively, our findings demonstrated that ADAM15 was connected with poor prognosis of HCC patients, and could be considered as a potential biomarker for the diagnosis and treatment of HCC.

UI MeSH Term Description Entries
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008297 Male Males
D008565 Membrane Proteins Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors. Cell Membrane Protein,Cell Membrane Proteins,Cell Surface Protein,Cell Surface Proteins,Integral Membrane Proteins,Membrane-Associated Protein,Surface Protein,Surface Proteins,Integral Membrane Protein,Membrane Protein,Membrane-Associated Proteins,Membrane Associated Protein,Membrane Associated Proteins,Membrane Protein, Cell,Membrane Protein, Integral,Membrane Proteins, Integral,Protein, Cell Membrane,Protein, Cell Surface,Protein, Integral Membrane,Protein, Membrane,Protein, Membrane-Associated,Protein, Surface,Proteins, Cell Membrane,Proteins, Cell Surface,Proteins, Integral Membrane,Proteins, Membrane,Proteins, Membrane-Associated,Proteins, Surface,Surface Protein, Cell
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D005260 Female Females
D006528 Carcinoma, Hepatocellular A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested. Hepatocellular Carcinoma,Hepatoma,Liver Cancer, Adult,Liver Cell Carcinoma,Liver Cell Carcinoma, Adult,Adult Liver Cancer,Adult Liver Cancers,Cancer, Adult Liver,Cancers, Adult Liver,Carcinoma, Liver Cell,Carcinomas, Hepatocellular,Carcinomas, Liver Cell,Cell Carcinoma, Liver,Cell Carcinomas, Liver,Hepatocellular Carcinomas,Hepatomas,Liver Cancers, Adult,Liver Cell Carcinomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old

Related Publications

Jun Hui Xu, and Yong Jun Guan, and Yi Chao Zhang, and Zhen Dong Qiu, and Yu Zhou, and Chen Chen, and Jia Yu, and Wei Xing Wang
January 2021, Frontiers in medicine,
Jun Hui Xu, and Yong Jun Guan, and Yi Chao Zhang, and Zhen Dong Qiu, and Yu Zhou, and Chen Chen, and Jia Yu, and Wei Xing Wang
December 2022, Aging,
Jun Hui Xu, and Yong Jun Guan, and Yi Chao Zhang, and Zhen Dong Qiu, and Yu Zhou, and Chen Chen, and Jia Yu, and Wei Xing Wang
January 2014, PloS one,
Jun Hui Xu, and Yong Jun Guan, and Yi Chao Zhang, and Zhen Dong Qiu, and Yu Zhou, and Chen Chen, and Jia Yu, and Wei Xing Wang
March 2023, IUBMB life,
Jun Hui Xu, and Yong Jun Guan, and Yi Chao Zhang, and Zhen Dong Qiu, and Yu Zhou, and Chen Chen, and Jia Yu, and Wei Xing Wang
January 2023, Journal of oncology,
Jun Hui Xu, and Yong Jun Guan, and Yi Chao Zhang, and Zhen Dong Qiu, and Yu Zhou, and Chen Chen, and Jia Yu, and Wei Xing Wang
January 2021, Journal of hepatocellular carcinoma,
Jun Hui Xu, and Yong Jun Guan, and Yi Chao Zhang, and Zhen Dong Qiu, and Yu Zhou, and Chen Chen, and Jia Yu, and Wei Xing Wang
January 2022, Journal of oncology,
Jun Hui Xu, and Yong Jun Guan, and Yi Chao Zhang, and Zhen Dong Qiu, and Yu Zhou, and Chen Chen, and Jia Yu, and Wei Xing Wang
December 2022, Aging,
Jun Hui Xu, and Yong Jun Guan, and Yi Chao Zhang, and Zhen Dong Qiu, and Yu Zhou, and Chen Chen, and Jia Yu, and Wei Xing Wang
January 2023, Contemporary oncology (Poznan, Poland),
Jun Hui Xu, and Yong Jun Guan, and Yi Chao Zhang, and Zhen Dong Qiu, and Yu Zhou, and Chen Chen, and Jia Yu, and Wei Xing Wang
January 2021, Journal of hepatocellular carcinoma,
Copied contents to your clipboard!